Journal of Drugs in Dermatology

Aims & Scope

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr.

Perry Robins MD.

Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.

We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.

Our high standards of content are maintained through a balanced, peer-review process.

Articles are reviewed by an International Editorial Board of over 160 renowned experts.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.8

h-index

Year	Value
2024	75

Journal Rank

Year	Value
2024	9278

Journal Citation Indicator

Year	Value
2024	1068

SJR (SCImago Journal Rank)

Year	Value
2024	0.624

Quartile

Year	Value
2024	Q2

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Impact of Iron-Oxide Containing Formulations Against Visible Light-Induced Skin Pigmentation in Skin of Color Individuals

  Citation: 57

  Authors: Hawasatu, Pearl, Stephen, Kalli, Manisha, Qian, Charbel, Janet

• The Therapeutic Use of Antioxidants for Melasma

  Citation: 41

  Authors: Kayla, Remy, Amor

• Probiotics Supplementation Improves Quality of Life, Clinical Symptoms, and Inflammatory Status in Patients With Psoriasis

  Citation: 37

  Authors: Jalal, Pourya, Hamed, Fatemeh, Armaghan, Hamidreza, Mahdi

• Impact of Atopic Dermatitis Lesion Location on Quality of Life in Adult Patients in a Real-world Study

  Citation: 36

  Authors: Peter, Andreas, Jacob, Evangeline, Maria, Amy, Jorge, Peter, Gary, James, Jonathan, Carle

• A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma

  Citation: 36

  Authors: Michael, Aaron, Reinhard, Nicholas, C. William

• Clinical Evaluation of a Nature-Based Bakuchiol Anti-Aging Moisturizer for Sensitive Skin

  Citation: 36

  Authors: Zoe, Hemali, Joshua, Stanley

• The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study

  Citation: 35

  Authors: Melinda, Leon, Matthew, Mark, Steven, Zoe, Laura, Terry, Etienne, Robert, Neal, Robert, Scott, Kimmie, Howard, Charlotte, Meg, Lynn, Robert, Michael, David

• Intradermal Microdroplet Injection of Diluted Incobotulinumtoxin-A for Sebum Control, Face Lifting, and Pore Size Improvement

  Citation: 32

  Authors: Je-Young, Soo, Keunyoung, Dong

• The Heterogeneity of Atopic Dermatitis

  Citation: 29

  Authors: R., J.I.

• Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies

  Citation: 29

  Authors: Adele, Raman

---